Skip to content
  • Sunday, 26 July 2026
  • 3:20 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Ensuring Monoclonality in Cell Cloning: Sartorius’s CellCelector Nanowell Technology Revolutionizes Biopharmaceutical Development
Biotech & Genetic Research

Ensuring Monoclonality in Cell Cloning: Sartorius’s CellCelector Nanowell Technology Revolutionizes Biopharmaceutical Development

Jia Lissa Apr 25, 2026 0

Ensuring monoclonality in cell cloning processes is a critical challenge in the biotechnology and pharmaceutical industries, where cell purity and…

Read More
Biotech & Genetic Research

The Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line Development

Jia Lissa Apr 15, 2026 0

Cell-line development (CLD) stands as a foundational pillar in the biopharmaceutical industry, an intricate and often arduous process critical for…

Read More
Bridging the Gap Between Neuroscience and Psychoanalysis How Modern Brain Models Echo Freudian TheoryExecutive War College 2026 to Spotlight AI, Workforce Solutions, and Financial Strategy for Clinical LabsStudy: Toxic Exposure in Pregnancy May Drive Disease Risk Across GenerationsRemepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ